← Back to Dashboard

Tamoxifen

Estrogen receptor antagonist

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3
NKANXQFJJICGDU-QPLCGJKRSA-N
ClinicalTrials.govPubMed

Clinical Development by Virus9

Hepacivirus C
HCV
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:17704057
Human immunodeficiency virus 1
HIV-1
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
NCT03382834 NCT03382834
Zaire ebolavirus
EBOV
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:23785035
Human alphaherpesvirus 1
HSV-1
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:24657267 NCT00749138
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:24841273
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:24841273
African swine fever virus
ASFV
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:33249093
Human coronavirus 229E
HCoV-229E
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:33249093
Lujo mammarenavirus
LUJV
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:34203149